Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anticancer activity of cis-dichlorodiammineplatinum(II) and some relevant chemistry.

× No keyword cloud information.

18 in total

1. Antitumorigenic Evaluation of Thalidomide Alone and in Combination with Cisplatin in DBA2/J Mice.

Authors: Jean Marie B. Ruddy; Shyamal K. Majumdar
Journal: J Biomed Biotechnol Date: 2002

2. Intracellular distribution of titanium after treatment with the antitumor agent titanocene dichloride: on electron energy loss spectroscopic study.

Authors: P Köpf-Maier; D Krahl
Journal: Naturwissenschaften Date: 1981-05

3. Differential effects of cisplatin on mouse hepatic and renal mitochondrial DNA.

Authors: E Maniccia-Bozzo; M B Espiritu; G Singh
Journal: Mol Cell Biochem Date: 1990-04-18 Impact factor: 3.396

4. Modification of the physicochemical and pharmacological properties of anticancer platinum compounds by commercial 5-fluorouracil formulations: a comparative study using cisplatin and carboplatin.

Authors: C Fournier; B Hecquet; G Bastian; D Khayat
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

Review 5. A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP.

Authors: B J Foster; B J Harding; M K Wolpert-DeFilippes; L Y Rubinstein; K Clagett-Carr; B Leyland-Jones
Journal: Cancer Chemother Pharmacol Date: 1990 Impact factor: 3.333

6. Copper(II) and manganese(III) complexes of N'-[(2-hydroxy phenyl) carbonothioyl] pyridine-2-carbohydrazide: novel therapeutic agents for cancer.

Authors: Anuraag Shrivastav; Nand K Singh; Pratibha Tripathi; Theresa George; Jonathan R Dimmock; Rajendra K Sharma
Journal: Biochimie Date: 2006-03-24 Impact factor: 4.079

Anticancer activity of cis-dichlorodiammineplatinum(II) and some relevant chemistry.

1. Antitumorigenic Evaluation of Thalidomide Alone and in Combination with Cisplatin in DBA2/J Mice.

2. Intracellular distribution of titanium after treatment with the antitumor agent titanocene dichloride: on electron energy loss spectroscopic study.

3. Differential effects of cisplatin on mouse hepatic and renal mitochondrial DNA.

4. Modification of the physicochemical and pharmacological properties of anticancer platinum compounds by commercial 5-fluorouracil formulations: a comparative study using cisplatin and carboplatin.

Review 5. A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP.

6. Copper(II) and manganese(III) complexes of N'-[(2-hydroxy phenyl) carbonothioyl] pyridine-2-carbohydrazide: novel therapeutic agents for cancer.

7. Combination Cancer Therapy of a Del1 Fragment and Cisplatin Enhanced Therapeutic Efficiency In Vivo.

8. Evidence for lack of mitochondrial DNA repair following cis-dichlorodiammineplatinum treatment.

9. Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats.

10. Comparative cytotoxicity between cisplatin and second generation platinum analogs.